Target Name: DAND5
NCBI ID: G199699
Review Report on DAND5 Target / Biomarker Content of Review Report on DAND5 Target / Biomarker
DAND5
Other Name(s): cerberus-like protein 2 | CRL2 | cerberus 2 | CKTSF1B3 | COCO | DANTE | CERL2 | cerberus-like 2 | DAN domain family, member 5 | DAND5_HUMAN | cerl-2 | GREM3 | SP1 | Cerl-2 | DAN domain family member 5 | DAN domain BMP antagonist family member 5 | Cerberus-like 2 | cysteine knot superfamily 1, BMP antagonist 3 | gremlin-3 | Cerberus 2 | Cerberus-like protein 2 | Gremlin-3 | CER2 | Cysteine knot superfamily 1, BMP antagonist 3 | DAN domain family member 5, BMP antagonist

DAND5: A Drug Target / Disease Biomarker

DAND5 is a protein that is expressed in various tissues of the body, including the brain, heart, liver, and pancreas. It is a member of the superfamily of cytoplasmic proteins, which are a type of protein that is found in all eukaryotic cells. DAND5 is characterized by its unique structure, which consists of a long alpha-helices region and a distinct beta-sheet region.

One of the key features of DAND5 is its ability to interact with various molecules, including small molecules, peptides, and proteins. This interactivity makes DAND5 an attractive target for drug development, as it allows scientists to study the effects of drugs on the activity of this protein.

DAND5 has also been shown to play a role in various physiological processes in the body. For example, DAND5 has been shown to be involved in the regulation of cell growth, differentiation, and survival. It has also been shown to play a role in the development and progression of various diseases, including cancer.

In addition to its potential as a drug target, DAND5 is also a potential biomarker for various diseases. Its interactivity with small molecules and proteins makes it a promising tool for the development of sensitive and specific diagnostic tests for a variety of diseases.

DAND5 is also a good candidate for a new type of therapy, called targeted therapy. This type of therapy aims to selectively target the cells or molecules that are causing a disease, rather than using a broad and potentially harmful treatment to all cells in the body. By using DAND5 as a target, scientists can develop new treatments that are more specific and less likely to cause harm to healthy cells.

Overall, DAND5 is a protein that has great potential as a drug target and biomarker. Its unique structure and ability to interact with a variety of molecules make it an attractive target for scientific research and drug development. Further studies are needed to fully understand the role of DAND5 in various physiological processes and to determine its potential as a diagnostic tool and therapy.

Protein Name: DAN Domain BMP Antagonist Family Member 5

Functions: Seems to play a role in the correct specification of the left-right axis. May antagonize NODAL and BMP4 signaling. Cystine knot-containing proteins play important roles during development, organogenesis, tissue growth and differentiation (By similarity)

The "DAND5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DAND5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

DANT2 | DAO | DAOA | DAOA-AS1 | DAP | DAP3 | DAPK1 | DAPK1-IT1 | DAPK2 | DAPK3 | DAPL1 | DAPP1 | DARS1 | DARS1-AS1 | DARS2 | DAW1 | DAXX | DAZ1 | DAZ2 | DAZ3 | DAZ4 | DAZAP1 | DAZAP2 | DAZAP2P1 | DAZL | DBET | DBF4 | DBF4B | DBF4P1 | DBH | DBH-AS1 | DBI | DBIL5P | DBIL5P2 | DBIP2 | DBIRD complex | DBN1 | DBNDD1 | DBNDD2 | DBNL | DBP | DBR1 | DBT | DBX1 | DBX2 | DCAF1 | DCAF10 | DCAF11 | DCAF12 | DCAF12L1 | DCAF12L2 | DCAF13 | DCAF13P3 | DCAF15 | DCAF16 | DCAF17 | DCAF4 | DCAF4L1 | DCAF4L2 | DCAF5 | DCAF6 | DCAF7 | DCAF8 | DCAF8L1 | DCAF8L2 | DCAKD | DCANP1 | DCBLD1 | DCBLD2 | DCC | DCD | DCDC1 | DCDC2 | DCDC2B | DCDC2C | DCHS1 | DCHS2 | DCK | DCLK1 | DCLK2 | DCLK3 | DCLRE1A | DCLRE1B | DCLRE1C | DCN | DCP1A | DCP1B | DCP2 | DCPS | DCST1 | DCST1-AS1 | DCST2 | DCSTAMP | DCT | DCTD | DCTN1 | DCTN1-AS1 | DCTN2 | DCTN3 | DCTN4